Work

Correction: Improving the therapeutic efficacy of sorafenib for hepatocellular carcinoma by repurposing disulfiram

Year: 2026

Type: erratum

Abstract: H, Cai L, Zhang L, Tanabe KK and Wang X (2022) Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram. Front. Oncol. 12:913736. doi: 10.3389/fonc.2022.913736In the published article, there was an error in Figure 2E as published. Some of the sphere images were unintentionally duplicated during the preparation process. The corrected Figure 2E and its caption appear below.

Source: Frontiers in Oncology

DOI: 10.3389/fonc.2026.1772315

Authors: Gong Zhang, Yufeng Wang, Bryan C. Fuchs, Wei Guo, David L. Drum, Derek J. Erstad, Baomin Shi, Albert B. DeLeo, Hui Zheng, Lei Cai, Liyuan Zhang, Kenneth K. Tanabe, Xinhui Wang

Institutions: Harvard University, Massachusetts General Hospital, First Affiliated Hospital of Zhengzhou University, Tongji University, Tongji Hospital

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,801

OpenAlex ID: W7130435748

Cites:

Cited by:

Related to: